BNB, Binance’s native cryptocurrency token, jumped to a new all-time high of more than $880 on Wednesday, August 20. This was despite its major treasury adopter, Windtree Therapeutics, announcing that…
In brief
Windtree confirmed its shares will be suspended from Nasdaq trading on Thursday for failing to meet the $1 minimum bid price.
Last month, it said it had committed to buy…
Windtree Therapeutics (WINT), a biotech firm listed on Nasdaq, has recently made headlines by venturing into the cryptocurrency space, particularly focusing on Binance Coin (BNB).
Just over a week after raising…
Windtree Therapeutics, a biotechnology company specializing in oncology and cardiovascular treatments, announced a new $520 million funding package to support a cryptocurrency treasury strategy focused on BNB token acquisition. According to…